- Home
- AMTX vs LPTX Comparison
AMTX vs LPTX Comparison
Compare AMTX & LPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMTX
- LPTX
- Stock Information
- Founded
- AMTX 2005
- LPTX 2011
- Country
- AMTX United States
- LPTX United States
- Employees
- AMTX N/A
- LPTX N/A
- Industry
- AMTX Major Chemicals
- LPTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AMTX Industrials
- LPTX Health Care
- Exchange
- AMTX Nasdaq
- LPTX Nasdaq
- Market Cap
- AMTX 128.6M
- LPTX 119.6M
- IPO Year
- AMTX N/A
- LPTX N/A
- Fundamental
- Price
- AMTX $2.84
- LPTX $2.55
- Analyst Decision
- AMTX Strong Buy
- LPTX Strong Buy
- Analyst Count
- AMTX 5
- LPTX 3
- Target Price
- AMTX $12.95
- LPTX $7.50
- AVG Volume (30 Days)
- AMTX 642.7K
- LPTX 335.2K
- Earning Date
- AMTX 03-06-2025
- LPTX 11-13-2024
- Dividend Yield
- AMTX N/A
- LPTX N/A
- EPS Growth
- AMTX N/A
- LPTX N/A
- EPS
- AMTX N/A
- LPTX N/A
- Revenue
- AMTX $291,400,000.00
- LPTX N/A
- Revenue This Year
- AMTX $64.91
- LPTX N/A
- Revenue Next Year
- AMTX $42.21
- LPTX N/A
- P/E Ratio
- AMTX N/A
- LPTX N/A
- Revenue Growth
- AMTX 59.51
- LPTX N/A
- 52 Week Low
- AMTX $2.10
- LPTX $1.68
- 52 Week High
- AMTX $7.03
- LPTX $4.79
- Technical
- Relative Strength Index (RSI)
- AMTX 47.22
- LPTX 37.35
- Support Level
- AMTX $2.56
- LPTX $2.88
- Resistance Level
- AMTX $2.92
- LPTX $3.27
- Average True Range (ATR)
- AMTX 0.20
- LPTX 0.28
- MACD
- AMTX 0.02
- LPTX -0.06
- Stochastic Oscillator
- AMTX 51.85
- LPTX 12.71
About AMTX Aemetis Inc. (DE)
Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into advanced biorefineries. It owns and operates an approximately 65 million gallon per year ethanol production facility located in Keyes, California. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. It operates in the reportable geographic segments of North America and India.
About LPTX Leap Therapeutics Inc.
Leap Therapeutics Inc is in developing targeted antibody therapies for cancer treatment, focusing on inhibiting tumor-promoting pathways, targeting cancer-specific cell surface molecules, and activating the immune system against cancer cells. The company's lead program, DKN-01, targets Dickkopf-related protein 1 (DKK1) and is in clinical trials for esophagogastric, gynecologic, and colorectal cancers. Their second program, FL-301, targets Claudin18.2-expressing cells. Additionally, the company has two preclinical antibody programs, FL-302 and FL-501, aimed at developing transformative cancer treatments. Operating as a single segment, the company's sole focus is on developing innovative drugs to address unmet needs in cancer therapy. .